Research Daily
Today's Must Read
Robust Content Aids Netflix (NFLX) Amid Stiff Competition
New Drugs to Drive Lilly's (LLY) Revenues in 2020
Dividends & Buybacks Boost UPS, High Capex Remains a Woe
Wednesday, February 5, 2020
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Netflix (NFLX), Eli Lilly (LLY) and United Parcel Service (UPS). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Netflix’s shares have underperformed the Zacks Broadcast Radio and Television industry over the past year (+4.8% vs. +7.8%). The Zacks analyst believes that Netflix’s fourth-quarter 2019 subscriber addition rate declined in the United States, primarily due to price hike and stiff competition.
However, in international streaming markets, Netflix’s subscriber growth continued unabated, driven by a solid content portfolio. Moreover, the launch of low-priced mobile plans in India, Indonesia and Malaysia is expected to expand the subscriber base in the Asia Pacific. However, management expects net additions in the paid subscriber base to decline in first-quarter 2020.
Moreover, high streaming content obligation and increased spending are expected to hurt free cash flow generation. Nevertheless, a solid content portfolio and expanding bundle offerings through partnerships with telcos bode well for Netflix.
(You can read the full research report on Netflix here >>>)
Shares of Eli Lilly have gained +28.8% in the past six months against the Zacks Large Cap Pharmaceuticals industry's rise of +15.1%. The Zacks analyst believes that in 2020, Lilly’s revenue growth is expected to be driven by higher demand for newer drugs including Trulicity, Jardiance, Taltz, Verzenio, Basaglar, Emgality as well as newly launched Baqsimi and Reyvow.
Lilly is making significant pipeline progress with several positive late-stage data readouts scheduled for 2020. Lilly is also regularly adding promising new pipeline assets through business development deals.
However, generic competition for several drugs including the expected generic entry of Forteo, rising pricing pressure in the United States and price cuts in some international markets are some top-line headwinds expected in 2020.
(You can read the full research report on Eli Lilly here >>>)
United Parcel Service’s shares have lost -15.2% over the past three months against the Zacks Transportation - Air Freight and Cargo industry's fall of -13.4%. The Zacks analyst believes that UPS' fourth-quarter 2019 performance was boosted by volume growth in the U.S. Domestic segment, its main revenue-generating unit.
Notably, segmental revenues increased 6.6% in 2019. E-commerce growth is a huge positive for UPS. We are also impressed by the company's efforts to reward its shareholders through dividends ($3.3 billion in 2019) and buybacks ($1 billion). However, UPS' high capital expenditures might play spoilsport.
Notably, 2020 capex is expected to be higher than 2019 levels. The same is expected to dent 2020 earnings per share by roughly 33 cents. The company's high debts add to its woes.
(You can read the full research report on United Parcel Service here >>>)
Other noteworthy reports we are featuring today include Microsoft (MSFT), Disney (DIS) and NIKE (NKE).
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>
Sheraz Mian
Director of Research
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Get the latest research report on MSFT - FREE
Get the latest research report on NKE - FREE
Get the latest research report on NFLX - FREE
Get the latest research report on LLY - FREE
Get the latest research report on UPS - FREE
Get the latest research report on DIS - FREE